Original studies long-term outcome in patients with st segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 6, 2014, Pages 912-922

  Manari, Antonio ^a   Varani, Elisabetta ^b   Guastaroba, Paolo ^c   Menozzi, Mila ^a   Valgimigli, Marco ^d   Menozzi, Alberto ^e   Magnavacchi, Paolo ^f   Franco, Nicoletta ^g   Marzocchi, Antonio ^h   Casella, Gianni ⁱ  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^c Regional Health Care and Social Agency   (Italy)

^d UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^e UNIVERSITY HOSPITAL OF PARMA   (Italy)

^f Nuovo Ospedale S Agostino   (Italy)

^g Ospedale Infermi   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ MAGGIORE HOSPITAL   (Italy)

Author keywords

Acute myocardial infarction; Angioplasty; Coronary artery disease; Stent

Indexed keywords

ACUTE MULTIVESSEL PRIMARY PERCUTANEOUS CORONARY INTERVENTION; AGE DISTRIBUTION; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CULPRIT ONLY PRIMARY PERCUTANEOUS CORONARY INTERVENTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE REGISTRY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVESSEL DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PROGNOSIS; RETROSPECTIVE STUDY; SELECTION BIAS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STAGED MULTIVESSEL PRIMARY PERCUTANEOUS CORONARY INTERVENTION; THERAPY DELAY; VASCULAR DISEASE; ADVERSE EFFECTS; CORONARY ARTERY DISEASE; HEMODYNAMICS; ITALY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; FEMALE; HEMODYNAMICS; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930089154     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25374     Document Type: Article

References (33)

1. Steg G, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van't Hof A, Widimsky P, Zahger D. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012;33: 2569-2619.
2. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343: 915-22.
3. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007;28:1709-1716.
4. Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV. Prevalence, predictors, and in-hospital outcomes of noninfarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol 2009;104:507-513.
5. Corpus RA, House JA, Marso SP, Grantham JA, Huber KC Jr, Laster SB, Johnson WL, Daniels WC, Barth CW, Giorgi LV, Rutherford BD. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004;148:493-500.
6. Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D. Impact of multivessel coronary artery disease and non-infarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry). Am J Cardiol 2010;106:342-347.
7. Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB 3rd. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. J Am Coll Cardl Intv 2010;3:22-31.
8. Jensen LO, Thayssen P, Farkas DK, Hougaard M, Terkelsen CJ, Tilsted H-H, Meng M, Junker A, Lassen JF, Horváth-Puhó E, Sørensen HT, Thuesen L. Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease. Eurointervention 2012;8:456-464.
9. Mohamad T, Bernal JM, Kondur A, Hari P, Nelson K, Niraj A, Badheka A, Hassna S, Kiernan T, Elder MD, Gardi D, Schreiber T. Coronary revascularization strategy for ST elevation myocardial infarction with multivessel disease: Experience and results at 1-year follow-up. Am J Ther 2011;18:92-100.
10. Qarawani D, Nahir M, Abboud M, Hazanov Y, Hasin Y. Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol 2008;123:288-292.
11. Rigattieri S, Biondi-Zoccai G, Silvestri P, Di Russo C, Musto C, Ferraiuolo G, Loschiavo P. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty. J Interv Cardiol 2008;21:1-7.
12. Roe MT, Cura FA, Joski PS, Garcia E, Guetta V, Kereiakes DJ, Zijlstra F, Brodie BR, Grines CL, Ellis SG. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol 2001;88:170-173.
13. van der Schaaf RJ, Claessen BE, Vis MM, Hoebers LP, Koch KT, Baan J Jr, Meuwissen M, Engstrom AE, Kikkert WJ, Tijssen JG, De Winter RJ, Piek JJ, Henriques JPS. Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock. Am J Cardiol 2010;105:955-959.
14. Toma M, Buller CE, Westerhout CM, Fu Y, O'Neill WW, Holmes DR Jr, Hamm CW, Granger CB, Armstrong PW for the APEX-AMI Investigators. Nonculprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: Insights from the APEX-AMI trial. Eur Heart J 2010;31:1701-1707.
15. Varani E, Balducelli M, Aquilina M, Vecchi G, Hussien MN, Frassineti V, Maresta A. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Cathet Cardiovasc Interv 2008;72:927-933.
16. Di Mario C, Mara S, Flavio A, Imad S, Antonio M, Anna P, Emanuela P, Stefano DS, Angelo R, Stefania C, Anna F, Carmelo C, Antonio C, Monzini N, Bonardi MA. Single vs multivessel treatment during primary angioplasty: Results of the multicentre randomised Hepacoat for Culprit or Multivessel Stenting for Acute Myocardial Infarction (HELP AMI) study. Int J Cardiovasc Intervent 2004;6:28-33.
17. Politi L, Sgura F, Rossi R, Monopoli D, Guerri E, Leuzzi C, Bursi F, Sangiorgi GM, Modena MG. A randomised trial of target-vessel versus multi-vessel revascularisation in STelevation myocardial infarction: Major adverse cardiac events during long-term follow-up. Heart 2010;96:662-667.
18. Khattab AA, Abdel-Wahab M, Röther C, Liska B, Toelg R, Kassner G, Geist V, Richardt G. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin Res Cardiol 2008; 97:32-38.
19. Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, Gersh BJ, Wong SC, Witzenbichler B, Guagliumi G, Dudek D, Fahy M, Lansky AJ, Stone GW, for the HORIZONS-AMI Trial Investigators. Prognostic Impact of staged versus One-Time multivessel percutaneous intervention in acute myocardial infarction: J Am Coll Cardiol 2011;58:704- 711.
20. Bangalore S, Kumar S, Poddar KL, Ramasamy S, Rha S-W, Faxon DP. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST segment elevation myocardial infarction and multivessel disease. Am J Cardiol 2011;107:1300-1310.
21. Vlaar PJ, Mahmoud KD, Holmes DR, van Valkenhoef G, Hillege HL, van der Horst ICC, Zijlstra F, De Smet BJGL. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: A pairwise and network meta-analysis. J Am Coll Cardiol 2011;58: 692-703.
22. Marzocchi A, Piovaccari G, Manari A, Aurier E, Benassi A, Saia F, Casella G, Varani E, Santarelli A, Guastaroba P, Grilli R, Maresta A. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. Am J Cardiol 2005;95:1409-1414.
23. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A science advisory from the AHA, ACC, SCAI, ACS, and ADA, with Representation from the ACP. J Am Coll Cardiol 2007;115:813-818.
24. Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, McCabe CH, Cannon CP, Antman EM, Braunwald E. Performance of the thrombolysis in Myocardial Infarction Risk Index in the National Registry of Myocardial Infarction-3 and -4: A simple index that predicts mortality in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004;44:783-789.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383.
26. Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, Ho PM, Kosiborod MN, Masoudi FA, Nallamothu BK. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: A report of the ACC/AHA Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2008;52:2046-2099.
27. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000.
28. Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: A comparison of methods. Am J Epidemiol 2005; 162:1016-1023.
29. D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation 2007;115:2340-2343.
30. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: Wiley; 1987.
31. Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998;54:948-963.
32. Wald DS, Morris JK, Wald NJ, et al. for the PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013;369:1115-1123.
33. De Bruyne B, Pijls NHJ, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991-1001.